"Less than a quarter of the pregnant women are screened for thyroid disorders currently. Less than 5 per cent women are counselled on thyroid disorders, prevention and treatment during antenatal care.
"There is not much difference between public health service providers and private health care settings when it comes to screening for thyroid and no difference between a Tier 1 or Tier 2 hospital," according to Frost & Sullivan Research which released two whitepapers today.
According to one of the whitepapers, congenital hypothyroidism situation in India is "alarming" with an abnormally high rate of 1 in 800 neonates as against a global average of 1 in 3,800 neonates (newborns) suffering from hypothyroidism.
"Hence universal screening of pregnant women and of neonates is critical. Congenital hypothyroidism requires early diagnosis (within the first seven days of birth), which is usually followed by appropriate therapy that can prevent the further brain damage," the research said.
The whitepapers also highlight that though the prevalence rate of diabetes (5.4 per cent) is lower than that of thyroid disease (10.95 per cent in non-pregnant context and 14.3 per cent in case of pregnant women), less is being done for thyroid screening and management in the health care sector in India.
It further claimed that pregnant women are at an "18-fold higher risk of hospitalisation" as compared to healthy non-pregnant women during both pandemic and inter-pandemic influenza periods.
"There is poor uptake of influenza vaccination during pregnancy in northern India. Among 1,000 women aged 18-41 years (13.6 per cent first trimester, 26.8 per cent second trimester), none was offered or received influenza vaccination," the whitepaper claimed.
Vandana Gurnani, Joint Secretary, Ministry of Health said, "India has made tremendous progress in bringing down maternal and child mortality over the years and this has been possible by introducing multiple interventions at various stages before, during and post pregnancy. These whitepapers show that now there is need to improve diagnosis and treatment of thyroid disorders and a possible need for vaccination for pregnant women.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
